In a bold stride for precision oncology and the Scottish biotech sector, Trogenix, a cutting-edge gene therapy company based in Edinburgh, has closed an €80 million Series A financing round to accelerate clinical development of its pioneering cancer treatments. The funding marks one of the largest early-stage biotech raises in Europe this year, placing the…
Cambridge-based Antler Bio, an emerging force in agricultural biotechnology, has announced a €3.6 million investment round to accelerate the deployment of its gene-expression platform, EpiHerd, across European dairy farms. The round was led by The First Thirty Ventures, with support from Endgame Capital and regenerative agriculture syndicate Generation-RE, bringing total capital raised to €7.2 million…
In a landmark moment for Scotland’s burgeoning biotech scene, uFraction8, a trailblazing engineering firm based in Falkirk, has clinched a £3.4 million investment to propel its cutting-edge microfiltration technology onto the global stage. The funding round, spearheaded by the visionary Foresight Group, marks a resounding vote of confidence in uFraction8‘s mission to revolutionize bioprocessing with…
A beacon of innovation has emerged from the serene shores of Lugano, as InVirtuoLabs secures €2.85 million in its inaugural funding round. This Swiss biotech pioneer, dedicated to reshaping the future of pharmaceuticals, is set to harness artificial intelligence to slash the staggering costs and timelines that have long burdened drug development. With this capital,…
Barcelona-based biotech firm Zymvol has announced a successful seed funding round, securing €3 million to further its mission of revolutionizing enzyme discovery and engineering. The funding, led by venture capital firms Faber Ventures, Elaia Partners, and Übermorgen Ventures, positions Zymvol to accelerate its market expansion and enhance its cutting-edge technology. Transforming the Enzyme Development Process…
In a significant boost for cancer therapy innovation, AvenCell Therapeutics, Inc. has announced the successful closure of a $112 million Series B funding round. The financing, spearheaded by Novo Holdings, attracted new investors including F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, and NYBC Ventures, alongside existing backer Blackstone Life Sciences. This funding…
In a significant boost for sustainable innovation, Belgian biotech startup AmphiStar has been awarded a €2 million grant from SPRIN-D, Germany’s Federal Agency for Disruptive Innovation. This funding marks a remarkable milestone for the company, bringing its total financing for 2023 to €10 million. The grant is aimed at advancing AmphiStar’s groundbreaking biotechnology platform, which…
In a significant boost for the cellular agriculture sector, foodtech startup Sallea has announced a successful funding round of $2.6 million, aimed at advancing the production of premium whole cuts of cultivated meat and fish. Founded in November 2023 by an innovative all-female team, Sallea is poised to redefine how cultivated proteins are produced, moving…
In a significant boost for biotechnology innovation, Nuclera has successfully closed a $75 million financing round, aimed at advancing its groundbreaking eProtein Discovery platform. This Series C round was led by Elevage Medical Technologies and saw participation from various prominent investors, including Patient Square Capital, British Patient Capital, Cambridge Innovation Capital, and others. This substantial…
Antiverse, a forward-thinking techbio company focused on antibody design for challenging therapeutic targets, has successfully raised an additional £3.5M ($4.6M) in its latest funding round. This investment elevates the total funding to £7.2M ($10.1M) and will significantly bolster Antiverse’s growth initiatives, including the expansion of its research facilities in Boston and Prague. The funding was…
